# Grid Dynamics Holdings, Inc.: financial statements, quarterly

GDYN · Nasdaq · CIK 1743725 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/gdyn.md) · [Financials](/companies/gdyn/financials.md) · [Filings](/companies/gdyn/filings.md) · [Insiders](/companies/gdyn/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/gdyn/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [77.4](/filings/0001628280-24-044572.md) | [78.1 d](/filings/0001743725-26-000007.md) | [79.8](/filings/0001628280-25-021584.md) | [83.0](/filings/0001628280-25-037042.md) | [87.4](/filings/0001743725-25-000010.md) | [100 d](/filings/0001743725-26-000007.md) | [100](/filings/0001743725-26-000014.md) | [101](/filings/0001743725-26-000021.md) | [104](/filings/0001743725-25-000010.md) | [106 d](/filings/0001743725-26-000007.md) | [104](/filings/0001743725-26-000014.md) | [108](/filings/0001743725-26-000021.md) |
| Cost of revenue | $m | [49.3](/filings/0001628280-24-044572.md) | [50.0 d](/filings/0001743725-26-000007.md) | [52.2](/filings/0001628280-25-021584.md) | [53.5](/filings/0001628280-25-037042.md) | [54.7](/filings/0001743725-25-000010.md) | [63.2 d](/filings/0001743725-26-000007.md) | [63.4](/filings/0001743725-26-000014.md) | [66.6](/filings/0001743725-26-000021.md) | [69.5](/filings/0001743725-25-000010.md) | [70.0 d](/filings/0001743725-26-000007.md) | [67.9](/filings/0001743725-26-000014.md) | [68.5](/filings/0001743725-26-000021.md) |
| Gross profit | $m | [28.2](/filings/0001628280-24-044572.md) | [28.1 d](/filings/0001743725-26-000007.md) | [27.7](/filings/0001628280-25-021584.md) | [29.6](/filings/0001628280-25-037042.md) | [32.7](/filings/0001743725-25-000010.md) | [37.0 d](/filings/0001743725-26-000007.md) | [37.0](/filings/0001743725-26-000014.md) | [34.5](/filings/0001743725-26-000021.md) | [34.7](/filings/0001743725-25-000010.md) | [36.1 d](/filings/0001743725-26-000007.md) | [36.2](/filings/0001743725-26-000014.md) | [39.6](/filings/0001743725-26-000021.md) |
| Research and development | $m | [3.4](/filings/0001628280-24-044572.md) | [3.9 d](/filings/0001743725-26-000007.md) | [4.4](/filings/0001628280-25-021584.md) | [4.1](/filings/0001628280-25-037042.md) | [4.4](/filings/0001743725-25-000010.md) | [5.4 d](/filings/0001743725-26-000007.md) | [6.5](/filings/0001743725-26-000014.md) | [6.7](/filings/0001743725-26-000021.md) | [5.8](/filings/0001743725-25-000010.md) | [4.7 d](/filings/0001743725-26-000007.md) | [6.1](/filings/0001743725-26-000014.md) | [6.4](/filings/0001743725-26-000021.md) |
| Selling, general and administrative | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $m | [0.1](/filings/0001628280-24-044572.md) | [(1.1) d](/filings/0001743725-26-000007.md) | [(5.5)](/filings/0001628280-25-021584.md) | [0.0](/filings/0001628280-25-037042.md) | [2.1](/filings/0001743725-25-000010.md) | [1.3 d](/filings/0001743725-26-000007.md) | [(2.0)](/filings/0001743725-26-000014.md) | [(0.1)](/filings/0001743725-26-000021.md) | [(0.2)](/filings/0001743725-25-000010.md) | [0.5 d](/filings/0001743725-26-000007.md) | [(3.7)](/filings/0001743725-26-000014.md) | [1.3](/filings/0001743725-26-000021.md) |
| Income tax | $m | [2.6](/filings/0001628280-24-044572.md) | [(1.4) d](/filings/0001743725-26-000007.md) | [0.9](/filings/0001628280-25-021584.md) | [3.5](/filings/0001628280-25-037042.md) | [1.3](/filings/0001743725-25-000010.md) | [1.2 d](/filings/0001743725-26-000007.md) | [(0.4)](/filings/0001743725-26-000014.md) | [2.0](/filings/0001743725-26-000021.md) | [1.9](/filings/0001743725-25-000010.md) | [2.5 d](/filings/0001743725-26-000007.md) | [1.0](/filings/0001743725-26-000014.md) | [1.6](/filings/0001743725-26-000021.md) |
| Net income | $m | [0.7](/filings/0001628280-24-044572.md) | [2.9 d](/filings/0001743725-26-000007.md) | [(3.9)](/filings/0001743725-25-000010.md) | [(0.8)](/filings/0001743725-25-000010.md) | [4.3](/filings/0001743725-25-000010.md) | [4.5 d](/filings/0001743725-26-000007.md) | [2.9](/filings/0001743725-26-000021.md) | [5.3](/filings/0001743725-26-000021.md) | [1.2](/filings/0001743725-25-000010.md) | [0.3 d](/filings/0001743725-26-000007.md) | [(1.5)](/filings/0001743725-26-000021.md) | [2.9](/filings/0001743725-26-000021.md) |
| Diluted EPS | $ per share | [0.01](/filings/0001628280-24-044572.md) | not reported | [(0.05)](/filings/0001628280-25-021584.md) | [(0.01)](/filings/0001628280-25-037042.md) | [0.05](/filings/0001743725-25-000010.md) | not reported | [0.03](/filings/0001743725-26-000014.md) | [0.06](/filings/0001743725-26-000021.md) | [0.01](/filings/0001743725-25-000010.md) | not reported | [(0.02)](/filings/0001743725-26-000014.md) | [0.03](/filings/0001743725-26-000021.md) |
| Basic EPS | $ per share | [0.01](/filings/0001628280-24-044572.md) | not reported | [(0.05)](/filings/0001628280-25-021584.md) | [(0.01)](/filings/0001628280-25-037042.md) | [0.06](/filings/0001743725-25-000010.md) | not reported | [0.03](/filings/0001743725-26-000014.md) | [0.06](/filings/0001743725-26-000021.md) | [0.01](/filings/0001743725-25-000010.md) | not reported | [(0.02)](/filings/0001743725-26-000014.md) | [0.03](/filings/0001743725-26-000021.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: not reported
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [254](/filings/0001628280-23-036440.md) | [257](/filings/0001743725-26-000007.md) | [249](/filings/0001628280-24-020035.md) | [256](/filings/0001628280-24-034187.md) | [231](/filings/0001628280-24-044572.md) | [335](/filings/0001743725-26-000007.md) | [326](/filings/0001743725-26-000014.md) | [337](/filings/0001743725-26-000021.md) | [339](/filings/0001743725-25-000010.md) | [342](/filings/0001743725-26-000021.md) | [327](/filings/0001743725-26-000014.md) | [298](/filings/0001743725-26-000021.md) |
| Current assets | $m | [326](/filings/0001628280-23-036440.md) | [324](/filings/0001628280-25-008723.md) | [323](/filings/0001628280-24-020035.md) | [330](/filings/0001628280-24-034187.md) | [323](/filings/0001628280-24-044572.md) | [423](/filings/0001743725-26-000007.md) | [422](/filings/0001628280-25-021584.md) | [433](/filings/0001628280-25-037042.md) | [441](/filings/0001743725-25-000010.md) | [440](/filings/0001743725-26-000021.md) | [432](/filings/0001743725-26-000014.md) | [410](/filings/0001743725-26-000021.md) |
| Total assets | $m | [436](/filings/0001628280-23-036440.md) | [435](/filings/0001628280-25-008723.md) | [435](/filings/0001628280-24-020035.md) | [444](/filings/0001628280-24-034187.md) | [477](/filings/0001628280-24-044572.md) | [592](/filings/0001743725-26-000007.md) | [591](/filings/0001628280-25-021584.md) | [609](/filings/0001628280-25-037042.md) | [613](/filings/0001743725-25-000010.md) | [613](/filings/0001743725-26-000021.md) | [605](/filings/0001743725-26-000014.md) | [600](/filings/0001743725-26-000021.md) |
| Current liabilities | $m | [52.5](/filings/0001628280-23-036440.md) | [42.2](/filings/0001628280-25-008723.md) | [43.1](/filings/0001628280-24-020035.md) | [46.3](/filings/0001628280-24-034187.md) | [54.2](/filings/0001628280-24-044572.md) | [55.5](/filings/0001743725-26-000007.md) | [58.2](/filings/0001628280-25-021584.md) | [58.7](/filings/0001628280-25-037042.md) | [57.8](/filings/0001743725-25-000010.md) | [52.1](/filings/0001743725-26-000021.md) | [54.9](/filings/0001743725-26-000014.md) | [56.9](/filings/0001743725-26-000021.md) |
| Total liabilities | $m | [62.8](/filings/0001628280-23-036440.md) | [52.3](/filings/0001628280-25-008723.md) | [52.5](/filings/0001628280-24-020035.md) | [55.2](/filings/0001628280-24-034187.md) | [77.0](/filings/0001628280-24-044572.md) | [74.4](/filings/0001743725-26-000007.md) | [73.5](/filings/0001628280-25-021584.md) | [76.7](/filings/0001628280-25-037042.md) | [75.4](/filings/0001743725-25-000010.md) | [70.8](/filings/0001743725-26-000021.md) | [74.9](/filings/0001743725-26-000014.md) | [80.4](/filings/0001743725-26-000021.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [373](/filings/0001628280-24-044572.md) | [383](/filings/0001743725-25-000010.md) | [383](/filings/0001743725-25-000010.md) | [388](/filings/0001743725-25-000010.md) | [400](/filings/0001743725-25-000010.md) | [518](/filings/0001743725-26-000007.md) | [517](/filings/0001743725-25-000010.md) | [532](/filings/0001743725-25-000010.md) | [538](/filings/0001743725-25-000010.md) | [542](/filings/0001743725-26-000021.md) | [530](/filings/0001743725-26-000014.md) | [520](/filings/0001743725-26-000021.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [11.0 d](/filings/0001628280-24-044572.md) | [7.6 d](/filings/0001743725-26-000007.md) | [3.2](/filings/0001628280-25-021584.md) | [10.7 d](/filings/0001628280-25-037042.md) | [9.2 d](/filings/0001743725-25-000010.md) | [7.1 d](/filings/0001743725-26-000007.md) | [9.4](/filings/0001743725-26-000014.md) | [14.4 d](/filings/0001743725-26-000021.md) | [7.0 d](/filings/0001743725-25-000010.md) | [9.9 d](/filings/0001743725-26-000007.md) | [8.4](/filings/0001743725-26-000014.md) | [6.1 d](/filings/0001743725-26-000021.md) |
| Capital expenditure | $m | [1.8 d](/filings/0001628280-24-044572.md) | [2.3 d](/filings/0001743725-26-000007.md) | [3.2](/filings/0001628280-25-021584.md) | [2.7 d](/filings/0001628280-25-037042.md) | [3.3 d](/filings/0001743725-25-000010.md) | [2.6 d](/filings/0001743725-26-000007.md) | [3.3](/filings/0001743725-26-000014.md) | [4.2 d](/filings/0001743725-26-000021.md) | [4.0 d](/filings/0001743725-25-000010.md) | [3.8 d](/filings/0001743725-26-000007.md) | [4.0](/filings/0001743725-26-000014.md) | [3.6 d](/filings/0001743725-26-000021.md) |
| Dividends paid | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | [0.0](/filings/0001743725-26-000014.md) | [0.0 d](/filings/0001743725-26-000021.md) | not reported | not reported | [11.5](/filings/0001743725-26-000014.md) | [17.3 d](/filings/0001743725-26-000021.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: not reported
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [68.6](/filings/0001628280-23-036440.md) | [74.5](/filings/0001628280-24-020035.md) | [76.9](/filings/0001628280-24-034187.md) | [77.3](/filings/0001628280-24-044572.md) | [76.2](/filings/0001628280-25-021584.md) | [76.6](/filings/0001628280-25-037042.md) | [78.8](/filings/0001743725-25-000010.md) | [87.8](/filings/0001743725-26-000014.md) | [86.4](/filings/0001743725-26-000021.md) | [85.8](/filings/0001743725-25-000010.md) | [84.7](/filings/0001743725-26-000014.md) | [83.0](/filings/0001743725-26-000021.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 81,126,881 at 2026-07-24, from the cover of the [10-Q filed 2026-07-30](/filings/0001743725-26-000021.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:47 ET. No prices; not investment advice.